[Pharmacotherapy of intestinal dysbacteriosis].

Abstract

The article presents a summary of the published literature together with results of the author's own investigations designed to study pharmacotherapy of intestinal dysbacteriosis. Reasons for the origination of the above medical condition are given, the particulars of its clinical presentation are specified. Clinical-and-pharmacological properties of chylac forte, a new effective probiotic, are detailed.

• Authors: I S Chekman
• Journal: Likars'ka sprava (Lik Sprava) 2000 Oct-Dec Issue 7-8 Pg. 6-11 ISSN: 1019-5297 [Print] Ukraine
• Vernacular Title: Farmakoterapiia dysbakteriosu kyshechnyka.
• PMID: 16786636 (Publication Type: English Abstract, Journal Article, Review)

Chemical References

• Anti-Bacterial Agents

Topics

• Anti-Bacterial Agents (administration & dosage, therapeutic use)
• Bacterial Infections (drug therapy, microbiology)
• Drug Therapy, Combination
• Humans
• Intestinal Diseases (drug therapy, microbiology)
• Probiotics (administration & dosage, therapeutic use)